This study was designed to improve the permeability of two drugs (finasteride and minoxidil) through the skin. Finasteride-loaded poly(lactic acid-co-glycolic acid) and minoxidil-loaded chitosan nanoparticles were prepared by nanoprecipitation and ionic gelation method, respectively, and subsequently incorporated into semisolid Carbopol 940 gel. These fabricated nanoparticles were characterized for their pharmaceutical and chemical behavior. Nanoparticles were found a nearly spherical shape in the scanning electron microscopic studies and exhibited particle size in a range of 211–1012 nm. Finasteride- and minoxidil-loaded nanoparticles were optimized for relatively higher entrapment efficiency of 98% and 95%, respectively, by using the optimal concentration of polymers and stabilizers. All formulations were clear with smooth homogeneous texture and having pH values compatible with that of skin. This nanoparticulate system suspended in gel prolonged the release of drugs for up to 24 h and enhanced the drug permeability through the skin and retention of drug-loaded nanoparticles within the hair follicular routes. Therefore, these nanoparticles incorporated in the gel were found as a promising candidate for topical application in the treatment of alopecia by reducing the dosing frequency and adverse effects and as an effective strategy for improving the patient compliance toward therapy.
AlsantaliA.Alopecia areata: a new treatment plan. Clin Cosmet Investig Dermatol2011; 4: 107–115.
2.
CaonTPortoLCGranadaA, et al. Chitosan-decorated polystyrene-b-poly (acrylic acid) polymersomes as novel carriers for topical delivery of finasteride. Eur J Pharm Sci2014; 52: 165–172.
3.
BalakrishnanPShanmugamSLeeWS, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm2009; 377(1): 1–8.
4.
MoserKKriwetKNaikA, et al. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm2001; 52(2): 103–112.
5.
KumarRPhilipA.Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res2007; 6(1): 633–644.
6.
GelfusoGMGratieriTSimaoPS, et al. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsul2011; 28(7): 650–658.
7.
ZhangZTsaiPCRamezanliT, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Nanomed Nanobiotechnol2013; 5(3): 205–218.
8.
AggarwalSGoelASinglaS.Drug delivery: special emphasis given on biodegradable polymers. Advanc Polym Sci Technol2012; 2(1): 1–15.
9.
DanhierFAnsorenaESilvaJM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release2012; 161(2): 505–522.
10.
LuckachanGEPillaiCKS. Biodegradable polymers—a review on recent trends and emerging perspectives. J Polym Envir2011; 19(3): 637–676.
11.
WilsonBSamantaMKSanthiK, et al. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomed Nanotechnol Biol Med2010; 6(1): 144–152.
12.
AgnihotriSAMallikarjunaNNAminabhaviTM.Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release2004; 100(1): 5–28.
13.
AbregoGAlvaradoHSoutoEB, et al. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: in vitro, ex vivo and in vivo characterization. Int J Pharm2016; 501(1): 350–361.
14.
AntonioJRAntonioCRCardealILS, et al. Nanotechnology in dermatology. Anais Brasil De Dermatol2014; 89(1): 126–136.
15.
LademannJRichterHTeichmannA, et al. Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm2007; 66(2): 159–164.
16.
ShahUJoshiGSawantK.Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. Mater Sci Engineer C2014; 35: 153–163.
17.
AhmedTA.Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation. Int J Nanomed2016; 11: 515–521.
18.
JafarinejadSGilaniKMoazeniE, et al. Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation. Powder Technol2012; 22: 265–270.
19.
PregoCPaolicelliPDíazB, et al. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine2010; 28(14): 2607–2614.
20.
BendasERAbdullahHEl-KomyMH, et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm2013; 458(2): 287–295.
21.
SurassmoSSaengkritNRuktanonchaiUR, et al. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Colloid Surf B: Biointerf2015; 130: 229–236.
22.
Morales-CruzMFlores-FernándezGMMorales-CruzM, et al. Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres. Results in Pharm Sci2012; 2: 79–85.
23.
MusumeciTVenturaCAGiannoneI, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm2006; 325(1): 172–179.
24.
CevherEOrhanZMülazımoğluL, et al. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm2006; 317(2): 127–135.
25.
GhasemianEVatanaraANajafabadiAR, et al. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. DARU J Pharm Sci2013; 21(1): 1–8.
26.
LuEFranzblauSOnyukselH, et al. Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion. J Microencap2009; 26(4): 346–354.
27.
BennetDMarimuthuMKimS, et al. Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery. Int J Nanomed2012; 7: 3399–3419.
28.
AbrarBAnisSTanuB, et al. Formulation and in-vitro evaluation of NSAID’s gel. Int J Current Pharm Res2012; 4(3): 56–58.
29.
HussainAKhanGMJanSU, et al. Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer. Pak J Pharm Sci2012; 25(2): 365–369.
30.
AhadAAqilMAliA.Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole. Int J Biolog Macromolecul2014; 64: 144–149.
31.
BachhavYGPatravaleVB.Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm2009; 365(1): 175–179.
32.
SonawaneRHardeHKatariyaM, et al. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opinion Drug Deliv2014; 11(12): 1833–1847.
33.
JainSMittalAJainA.Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Cur Nanosci2011; 7(4): 524–530.
34.
ShimJKangHSParkW-S, et al. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Release2004; 97(3): 477–484.
35.
MuLFengS.A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J Control Release2003; 86(1): 33–48.
36.
AlimohammadiYHJooSW.PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev2014; 15: 517–535.
37.
SejuUKumarASawantK.Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater2011; 7(12): 4169–4176.
38.
MuthuMSRawatMKMishraA, et al. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomed Nanotechnol Biol Med2009; 5(3): 323–333.
39.
VivekKReddyHMurthyRS.Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech2007; 8(4): 16–24.
40.
SrivastavaAYadavTSharmaS, et al. Polymers in drug delivery. J Biosci Med2015; 4(01): 69–75.
41.
VenkateshDNBaskaranMKarriVVSR, et al. Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Saudi Pharm J2015; 23(6): 667–674.
42.
HamoudehMAl FarajACanet-SoulasE, et al. Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int J Pharm2007; 338(1): 248–257.
43.
IbrahimMMAbd-ElgawadA-EHSolimanOA-E. Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in vitro study. J Pharm Technol Drug Res2013; 2(1): 7–16.
44.
FanWYanWXuZ, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloid Surf B: Biointerf2012; 90: 21–27.
45.
JanaSMannaSNayakAK, et al. Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. Colloid Surf B: Biointerf2014; 114: 36–44.
46.
AmidiMMastrobattistaEJiskootW, et al. Chitosan-based delivery systems for protein therapeutics and antigens. Advanc Drug Deliv Rev2010; 62(1): 59–82.
47.
SunYWanA.Preparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromolecules. J Appl Polym Sci2007; 105(2): 552–561.
48.
SharmaDSharmaRKSharmaN, et al. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS PharmSciTech2015; 16(5): 1108–1121.
49.
AhmedTAKhalidM.Transdermal film-loaded finasteride microplates to enhance drug skin permeation: two-step optimization study. Eur J Pharm Sci2016; 88: 246–256.
50.
TsujimotoHHaraKTsukadaY, et al. Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects. Bioorg Medicinal Chem Lett2007; 17(17): 4771–4777.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
